Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial
Crossref DOI link: https://doi.org/10.1186/s13063-015-0626-0
Published Online: 2015-03-26
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nashan, Bjorn
Schemmer, Peter
Braun, Felix
Dworak, Markus
Wimmer, Peter
Schlitt, Hans
License valid from 2015-03-26
Article History
Received: 19 December 2014
Accepted: 2 March 2015
First Online: 26 March 2015